Silo Pharma, Inc. has announced an agreement with Frontage Laboratories to conduct a 7-day safety and toxicology study on its lead drug, SPC-15, an intranasal treatment for PTSD. This study aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results